| Metric | Value ($ M) | Q1 FY26 | Q2 FY25 |
|---|---|---|---|
| Revenue | 20.2K | 5.9% | 8.7% |
| Total Income | 20.2K | 5.9% | 8.7% |
| Expenditure | 17.7K | 5.4% | 9.6% |
| PBT | 2.5K | 9.1% | 3.3% |
| Net Profit | 1.7K | 4.9% | 2.8% |
| OPM | — | ||
| NPM | 8.40% | 0.08pp | 0.49pp |
| EPS | 7.70 | 6.2% | 11.4% |
HCA Healthcare Previews Q2 2026 Results and Revises 2026 Guidance
14 Jul 2026 · 14 Jul, 5:16 pm
Summary
HCA Healthcare announced preliminary results for the second quarter of 2026, with anticipated revenues of approximately $20.230 billion, up from $18.605 billion in the prior year quarter. Net income is expected to be around $1.699 billion, or $7.62 per diluted share. The company also revised its full-year 2026 guidance, projecting revenues between $77.000 and $79.500 billion and Adjusted EBITDA between $15.400 and $16.100 billion. Management cited the need to adjust guidance due to factors impacting the first half of the year, including a payer mix shift and a service mix shift, while remaining confident in navigating the dynamic environment.
Key Highlights
- 1
HCA Healthcare anticipates second quarter 2026 revenues to approximate $20.230 billion, an increase from $18.605 billion in the second quarter of 2025.
- 2
Expected net income attributable to HCA Healthcare, Inc. for the second quarter of 2026 is approximately $1.699 billion, or $7.62 per diluted share.
- 3
Adjusted EBITDA for the second quarter of 2026 is expected to approximate $4.027 billion, compared to $3.849 billion in the second quarter of 2025.
- 4
Same facility admissions increased 2.5 percent and same facility equivalent admissions increased 2.7 percent in the second quarter of 2026 compared to the prior year period.
- 5
Same facility emergency room visits increased 3.6 percent in the second quarter of 2026 compared to the prior year period.
- 6
The company has revised its 2026 full-year revenue guidance to a range of $77.000 to $79.500 billion.
- 7
The company has revised its 2026 full-year Adjusted EBITDA guidance to a range of $15.400 to $16.100 billion.
Management Comments
Sam Hazen
Our colleagues continue to manage well through the positive and negative factors that have impacted our business in the first half of the year, and I want to thank them for their great work. As we look to the balance of the year, we have adjusted our guidance to reflect these factors. Moreover, we remain confident in our ability to navigate through this dynamic environment, maintain our focus and investments on improving patient care, and execute on our strategic plan to digitize and grow our healthcare networks.
Informational and educational content only. Not investment advice.